Diane Kamen to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Diane Kamen has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.302
-
Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis. Arthritis Rheumatol. 2021 01; 73(1):121-131.
Score: 0.177
-
Safety and Efficacy of Belimumab to Treat Systemic Lupus Erythematosus in Academic Clinical Practices. J Rheumatol. 2015 Dec; 42(12):2288-95.
Score: 0.125